U.S. Sleep Aids Market Grows To $23 Billion, As Americans Battle Insomnia, Sleep Disorders

Share Article

Home Tests, Sleep Labs, New Drugs Will Boost Growth

Marketdata Enterprises, Inc. (http://www.marketdataenterprises.com), a leading independent market research publisher, has released a groundbreaking new 145-page market study entitled: ''The U.S. Sleep Market.'' This is a complete analysis of all segments of the United States sleep aids business.

"Of a total population of 305 million Americans, 58% are estimated to experience insomnia symptoms or sleep disorders. Companies across America are trying to sell us a perfect night's sleep with sleeping pills, premium mattresses, high tech pillows, white noise machines, sleep masks, aromatherapy, and more. Sleep disorder diagnosis and sleep hygiene has fast become a $23.7 billion a year industry," according to Research Director, John LaRosa.

Major Findings:

  • Marketdata estimates that the U.S. sleep market was worth $23.7 billion in 2007. However, growth this year will be less than 1%, due to the recession, more home testing, and more generic sales of sleeping pills. To 2012, we forecast 8.8% annual growth.
  • The major anti-insomnia drug producers spent $619 million last year advertising Ambien CR, Lunesta and Rozerem, producing $2.7 billion in sales. However, this was down 18% as Ambien came off patent and sales of generics rose. New drugs are in the pipeline.
  • Sleep Labs, which perform studies to diagnose sleep disorders, are estimated to number 3,300+. The typical lab has revenues of $1.33 million and conducts 1,250 studies per year. Labs are located in hospitals, MD practices, universities, or are independent. This segment will be worth $4.47 billion in 2008.
  • A March 2008 ruling by the Center for Medicare Services will have a major impact on the field of sleep medicine. Portable devices may now be used for home testing, resulting in short-term uncertainties for sleep labs but boosting the market for CPAP devices - a $2.4 billion market that's growing 18% a year to 2012 and that's dominated by ResMed and Respironics.
  • The huge $13.7 billion retail mattress market and $900 million pillows market are being hurt by the recession. Retail sales are forecast to grow just 1% this year, but to rebound in 2009. Premium non-innerspring (air, memory foam) models are selling well.

According to Research Director, John LaRosa: "As obesity rates climb and Americans age, more people are developing sleep apnea, restless legs syndrome and other sleep disorders. Plus, stressors from the economy, terrorism, longer workdays, and women entering menopause are resulting in more sleepless nights. Some claim that 'sleep is the new sex -- we need more of it and can't get enough of it.' First launched in 1977, there are now about 3,300 'sleep labs' in the United States."

Competitor Profiles provided for: ResMed, Respironics, SleepMed, Sleep Solutions, Sleep Holdings, Avastra Sleep Centres, Tempur-Pedic, Sealy, Serta, Select Comfort, Simmons, Apollo Health, and Marpac.

Note: Marketdata also operates a leading consumer healthcare website covering a wide variety of sleep disorder topics, named: http://www.sleepweb.com .

About the Report & Marketdata

Marketdata Enterprises is a leading independent market research publisher and consulting firm with a specialty tracking service sectors since 1979.

The ''U.S. Sleep Market,'' published in June 2008, is a complete analysis of the sleep aids market. It contains 25 tables and is 145 pages long. The study costs $1,895, but is sold by individual chapters at lower cost. It is available in digital or print format. This new Marketdata study examines all major market segments: anti-insomnia drugs (OTC & prescription), sleep labs, mattresses and pillows, CPAPs (continuous positive airway pressure devices) for sleep apnea, and retail sleep aids (earplugs, sleep lamps, sound machines, eye masks, books on sleep).

Marketdata performed a custom mail survey of 900+ sleep labs in March-May, deriving key operating ratios, average revenues, patient demographics, and more.

The study includes market size estimates for 1987-2007, with 2008 and 2012 forecasts, client demographics, in-depth competitor profiles and rankings in each market segment, discussions of market nature & structure, history and evolution, in view of recent Medicare rulings regarding home testing. Advertising strategies, R&D, sleep disorder publicity and other demand factors analyzed.

Contact Information:

John LaRosa, Research Director
Marketdata Enterprises, Inc.,
Phone: 813-931-3900. Fax: 813-931-3802


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website